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Addendum: Genome-wide association study of
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Addendum to: Nature Communications; https://doi.org/10.1038/s41467-018-03819-3; published online 16 Apr 2018
In this article, a meta-analysis of the signiﬁcant variants in the UK Biobank sample with a previously published study by 23andMe was
included. Due to the individual study results being reported on different scales, the meta-analytic point estimates were not reliable. We
have re-analysed the 17 signiﬁcant variants in the UK Biobank using a comparable approach to 23andMe in Plink. We present an
updated version of Table 1 associated with this Addendum that includes the newly calculated comparable effect size estimates for UK
Biobank, the updated meta-analysis results and we have extended the table legend to provide information on the updated columns. As
a consequence of the new analysis, the original statement in the ﬁrst paragraph under the subheading “Genome-wide association
study of depression” reading “All 17 variants remained signiﬁcant (P < 5 × 10−8) in the meta-analysis” should be amended to
“10 variants remained signiﬁcant (P < 5 × 10−8) in the meta-analysis”. There was no change to the direction of allelic effect in either
cohort.
The fourth sentence in Methods section under the subheading “Replication cohort and meta-analysis” on page 8 was incomplete and
should read “Additionally, we used Metal36 to conduct an inverse variance-weighted meta-analysis, using LD score regression
intercepts13 for genomic inﬂation control.”, adding “using LD score regression intercepts13 for genomic inﬂation control” at the end of
the sentence.
We have also included transformed effect sizes and standard errors in our summary statistics deposited on the Edinburgh DataShare
website and have updated the doi to https://doi.org/10.7488/ds/2350.
In a second related issue, we used the new BGENIE software package to generate the results with which to conduct gene, region
and gene-set analyses to generate data presented in the “Gene and region-based analysis” and “Gene-set pathway analysis”
sections, Table 2, Supplementary Table 6, Supplementary Data 6–12, and Supplementary Figures 7–9. BGENIE reported minor
allele frequencies (MAF) across the whole of UK Biobank (n= 487,409) rather than based on those individuals that were
included in each of the association analyses (broad depression n= 322,580; probable major depressive disorder n= 174,519;
International Classiﬁcation of Diseases-coded major depressive disorder n= 217,584). Therefore the results reported in the
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“Gene and region-based analysis” and “Gene-set pathway analysis” were based on the MAF across the whole of UK Biobank as
opposed to what we described in the methods section. To correct these errors in our initial analysis, we have now re-analysed the
data using the MAF based on only those individuals included in the respective association analysis. This has resulted in 73
rather than 78 signiﬁcant genes for broad depression, three rather than two genes for probable MDD, and zero genes rather than
one gene for ICD-coded MDD which was originally described in the “Gene and region-based analysis” section in the results. The
gene-based results descri bed on page 3 under the subheading “Gene and region-based analyses” should read “We used the
MAGMA18 package to identify genes with a signiﬁcant effect (P < 2.77 × 10−6) on each phenotype. There were 73 genes
signiﬁcantly associated with broad depression (Supplementary Data 6, associated with this Addendum), and three genes that
were associated with probable MDD (Supplementary Data 7, associated with this Addendum)”. Updated versions of Supple-
mentary Note 1, Supplementary Figures 7, 8, and 9 in the Supplementary Information ﬁle, and Supplementary Data 6 and 7 are
included here to reﬂect these changes in the data. The original Supplementary Data 8 should be disregarded as with the new
analysis no genome-wide signiﬁcant SNPs for ICD-coded MDD are detected. In the region-based analysis described on page 3
number of regions assessed increased from 8308 to 8345 requiring a slight change in the signiﬁcance threshold from 6.02 × 10−8
to 5.99 × 10−6 so that the sentence in the second paragraph under the subheading “Gene and region-based analyses” now
reads “We also used MAGMA to identify genomic regions, deﬁned by recombination hotspots, with a statistically signiﬁcant
effect (P < 5.99 × 10−6) on each phenotype”. The number of signiﬁcant regions remained the same and updated estimates of
effect sizes of regions may be found in the updated Supplementary Data 8, 10, and 11 associated with this Addendum. The
signiﬁcant gene-sets described under the subheading “Gene-set pathway analysis” remained the same with slight differences in
number of genes in each pathway, effect sizes and p-values. The ﬁrst sentence in this section now reads: “We conducted gene-set
enrichment analysis19,20 and identiﬁed ﬁve signiﬁcant pathways for broad depression after applying correction for multiple
testing; GO_EXCITATORY_SYNAPSE (beta= 0.342 ± 0.069, Pcorrected= 0.003), GO_MECHANOSENSORY_BEHAVIOR
(beta= 1.270 ± 0.294, Pcorrected= 0.047), GO_POSTSYNAPSE (beta= 0.248 ± 0.050, Pcorrected= 0.003), GO_NEURON_SPINE
(beta= 0.390 ± 0.089, Pcorrected= 0.019) and GO_DENDRITE (beta= 0.200 ± 0.044, Pcorrected= 0.021) (Table 2)”. Amended
versions of Table 2, Supplementary Data 12 and Supplementary Table 6 in the Supplementary Information ﬁle are included in
this Addendum.
Table 2 Pathways with a signiﬁcant effect (Pcorrected < 0.05) on broad depression following multiple testing correction identiﬁed
through gene-set enrichment analysis
Phenotype Pathway Number of genes Beta (St. Err.) P-value PCorrected
Broad depression GO_EXCITATORY_SYNAPSE 184 0.342 (0.069) 3.45 × 10−7 0.003
GO_POSTSYNAPSE 354 0.248 (0.050) 3.88 × 10−7 0.003
GO_NEURON_SPINE 115 0.390 (0.089) 2.72 × 10−6 0.019
GO_DENDRITE 425 0.200 (0.044) 3.08 × 10−6 0.021
GO_MECHANOSENSORY_BEHAVIOR 12 1.270 (0.294) 8.04 × 10−6 0.047
Table 1 Independent variants with a genome-wide signiﬁcant (P < 5 × 10−8) association with broad depression, probable major
depressive disorder (MDD), or International Classiﬁcation of Diseases (ICD)-coded MDD in the UK Biobank
UK Biobank 23andMe Meta-analysis
Phenotype Chr Marker
name
Position A1/
A2
Freq Info log OR (St Err) P-value Gene ± 10
kb
log OR (St Err) P-value log OR (St Err) P-value Direction
Broad
depression
1 rs10127497 67050144 T/A 0.138 1.00 0.044 (0.0077) 1.26 × 10−8 SGIP1 0.0098 (0.0086) 0.257 0.029 (0.0058) 5.70 × 10−7 ++
1 rs6699744 72825144 T/A 0.612 1.00 0.040 (0.0055) 1.64 × 10−13 — 0.0328 (0.0064) 2.68 × 10−7 0.0372 (0.0042) 9.76 × 10−19 ++
1 rs6424532 73664022 A/G 0.486 1.00 0.029 (0.0053) 3.74 × 10−8 — 0.0233 (0.006) 1.14 × 10−4 0.0267 (0.004) 4.10 × 10−11 ++
1 rs7548151 177026983 A/G 0.084 1.00 0.056 (0.0095) 3.77 × 10−9 ASTN1 0.006 (0.0104) 0.560 0.0339 (0.0071) 1.97 × 10−6 ++
5 rs40465 103981726 G/T 0.332 1.00 0.035 (0.0056) 4.37 × 10−10 RP11-6N13.1 0.0193 (0.0064) 2.63 × 10−3 0.0285 (0.0043) 3.53 × 10−11 ++
6 rs3132685 29945949 A/G 0.130 1.00 −0.059 (0.0081) 2.48 × 10−13 — −0.0249 (0.0099) 0.0115 −0.0459 (0.0063) 4.87 × 10−13 −−
6 rs112348907 73587953 G/A 0.296 1.00 0.033 (0.0058) 1.44 × 10−8 — −0.0004 (0.0067) 0.950 0.019 (0.0045) 2.06 × 10−5 +−
7 rs3807865 12250402 A/G 0.412 1.00 0.037 (0.0054) 6.81 × 10−12 TMEM106B 0.019 (0.0061) 0.002 0.0293 (0.0041) 8.79 × 10−13 ++
7 rs2402273 117600424 C/T 0.409 1.00 0.032 (0.0054) 1.88 × 10−9 — 0.0093 (0.0061) 0.130 0.0226 (0.0041) 3.97 × 10−8 ++
9 rs263575 17033840 A/G 0.460 1.00 −0.030 (0.0053) 2.36 × 10−8 — −0.0157 (0.0061) 9.45 × 10−3 −0.0238 (0.0041) 4.51 × 10−9 −−
10 rs1021363 106610839 G/A 0.642 1.00 −0.032 (0.0055) 1.02 × 10−8 SORCS3 −0.031 (0.0063) 9.34 × 10−7 −0.0314 (0.0042) 1.04 × 10−13 −−
11 rs10501696 88748162 G/A 0.499 0.99 −0.036 (0.0054) 6.42 × 10−11 GRM5 −0.0251 (0.0066) 1.49 × 10−4 −0.0315 (0.0043) 1.55 × 10−13 −−
13 rs9530139 31847324 T/C 0.195 1.00 −0.040 (0.0067) 2.59 × 10−9 B3GLCT −0.0075 (0.0078) 0.338 −0.0265 (0.0052) 2.77 × 10−7 −−
15 rs28541419 88945878 G/C 0.231 1.00 −0.035 (0.0064) 2.82 × 10−8 — −0.0029 (0.0073) 0.688 −0.0218 (0.0049) 7.75 × 10−6 −−
Probable
MDD
2 rs10929355 15398964 G/T 0.456 1.00 −0.053 (0.0090) 5.89 × 10−9 NBAS −0.0078 (0.0061) 0.199 −0.0221 (0.0051) 1.62 × 10−5 −−
7 rs5011432 12268668 C/A 0.412 1.00 0.051 (0.0091) 2.10 × 10−8 TMEM106B 0.022 (0.0061) 3.15 × 10−4 0.0313 (0.0052) 1.47 × 10−9 ++
ICD-coded
MDD
7 rs1554505 1983929 A/G 0.752 1.00 0.114 (0.0191) 2.73 × 10−9 MAD1L1 0.017 (0.007) 0.015 0.0291 (0.0068) 1.63 × 10−5 ++
The UK Biobank results are from logistic regression analyses in PLINK of variants identiﬁed as genome-wide signiﬁcant using BGENIE. Variants were examined within the 23andMe association analysis of
depression4 to obtain their reported P-values and determine whether their effect was in the same direction as UK Biobank. The allele frequency (Freq) is for the A1 allele within UK Biobank, with the
effect size (Log OR) and standard error (St. err.) reported for the A1 allele within UK Biobank, 23andMe and the meta-analysis. The chromosome (Chr) and basepair position is given for the GRCh37
assembly. Imputation accuracy (Info) score of UK Biobank was calculated based on the sample analysed
ADDENDUM NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05310-5
2 NATURE COMMUNICATIONS |  (2018) 9:3578 | DOI: 10.1038/s41467-018-05310-5 | www.nature.com/naturecommunications
The described errors have not been ﬁxed in the original article. We reafﬁrm that the changes do not change the main conclusions of the
manuscript.
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